University OF Texas/texas AM Investment Management Co., 10% Owner at Aileron Therapeutics, Inc. (ALRN), sold 20,315 shares at $4.32 ($85K) on 2024-05-01, disclosed to the SEC on 2024-05-14.
Open-market sale of $85k ALRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.10 | 3,100 | $13K | 14.9% |
| 2 | $4.11 | 100 | $411 | 0.5% |
| 3 | $4.12 | 1,750 | $7K | 8.4% |
| 4 | $4.13 | 380 | $2K | 1.8% |
| 5 | $4.15 | 1,600 | $7K | 7.8% |
| 6 | $4.15 | 670 |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateSilver Point Specialty Lending Fund | BUY | 2026-03-02 | $6.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY |
| $3K |
| 3.3% |
| 7 | $4.18 | 400 | $2K | 2.0% |
| 8 | $4.25 | 7,923 | $34K | 39.4% |
| 9 | $4.26 | 310 | $1K | 1.5% |
| 10 | $4.27 | 100 | $427 | 0.5% |
| 11 | $4.27 | 317 | $1K | 1.6% |
| 12 | $4.28 | 337 | $1K | 1.7% |
| 13 | $4.28 | 200 | $856 | 1.0% |
| 14 | $4.29 | 2,903 | $12K | 14.6% |
| 15 | $4.29 | 200 | $858 | 1.0% |
| 16 | $4.32 | 25 | $108 | 0.1% |
| Total | $4.21 avg | 20,315 | $85K | 100% |
| 2026-02-02 |
| $9.7M |
| — |
| Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-12-29 | $8.6M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-11-26 | $8.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-10-27 | $7.6M | — | Filing → |